𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P125 Rituximab in the treatment of lymphoid malignancies: a municipal hospital experience

✍ Scribed by Gy. Ujj; E. Szabó; L. Olexik; P. Pettendi; Gy. Bakondi

Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
59 KB
Volume
21
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic potential of purine analogue
Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies
✍ S. A. Johnson; W. Thomas 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The main purine analogues with activity against lymphoid malignancies are fludarabine, cladribine and pentostatin, all of which are active against slowly proliferating cells through their inhibition of DNA repair and therefore have significant synergistic activity with cytotoxic agents which cause D

Plasmapheresis in the treatment of hyper
Plasmapheresis in the treatment of hypertriglyceridemia-induced pancreatitis: A community hospital's experience
✍ H. Syed; M. Bilusic; C. Rhondla; A. Tavaria 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract **Background:** Hyperlipidemic pancreatitis is a potentially fatal complication of hypertriglyceridemia (HTG). The current mainstay of treatment for the hypertriglyceridemia associated with pancreatitis includes heparin, insulin and lipid lowering agents. Experiences with plasmapheresis

In-hospital complications of autologous
In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies : Clinical and economic outcomes from the nationwide inpatient sample
✍ Jeffrey A. Jones; Muzaffar H. Qazilbash; Ya-Chen T. Shih; Scott B. Cantor; Cathe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

## Abstract ## BACKGROUND. Autologous hematopoietic stem cell transplantation (auto HSCT) is standard of care therapy for multiple myeloma and Hodgkin and non‐Hodgkin lymphomas in front‐line and salvage settings, respectively. Complications remain common, but population‐based estimates of their fr